Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Tobi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 9, 2025
Peptide-targeted nanoparticles for tumor therapyValeria Sidorenko, Allan Tobi, Kazuki N Sugahara, et al.
Scientific Reports|August 11, 2025
Targeting oncofetal fibronectin and neuropilin-1 in solid tumors with PL2 peptidePrakash Lingasamy, Allan Tobi, Kaarel Kurm, et al.
Nano Letters|February 9, 2017
Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor GrowthShweta Sharma, Venkata Ramana Kotamraju, Tarmo Mölder, et al.
Nucleic Acids Research|January 14, 2021
In vivo phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissuesKarlis Pleiko, Kristina Põšnograjeva, Maarja Haugas, et al.
Pharmaceutics|December 28, 2021
PL1 Peptide Engages Acidic Surfaces on Tumor-Associated Fibronectin and Tenascin Isoforms to Trigger Cellular UptakePrakash Lingasamy, Kristina Põšnograjeva, Sergei Kopanchuk, et al.
Nanomaterials (Basel, Switzerland)|December 24, 2021
Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in EndometriosisLorena Simón-Gracia, Kristina Kiisholts, Vilma Petrikaitė, et al.
Scientific Reports|April 4, 2020
Tumor-penetrating peptide for systemic targeting of Tenascin-CPrakash Lingasamy, Allan Tobi, Kaarel Kurm, et al.
Drug Delivery and Translational Research|July 16, 2024
Protease-activated CendR peptides targeting tenascin-C: mitigating off-target tissue accumulationAllan Tobi, Maarja Haugas, Kristina Rabi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 13, 2017
Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticlesHedi Hunt, Lorena Simón-Gracia, Allan Tobi, et al.
Biomaterials|August 3, 2019
Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor deliveryPrakash Lingasamy, Allan Tobi, Maarja Haugas, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 9, 2025
Peptide-targeted nanoparticles for tumor therapyValeria Sidorenko, Allan Tobi, Kazuki N Sugahara, et al.
Scientific Reports|August 11, 2025
Targeting oncofetal fibronectin and neuropilin-1 in solid tumors with PL2 peptidePrakash Lingasamy, Allan Tobi, Kaarel Kurm, et al.
Nano Letters|February 9, 2017
Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor GrowthShweta Sharma, Venkata Ramana Kotamraju, Tarmo Mölder, et al.
Nucleic Acids Research|January 14, 2021
In vivo phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissuesKarlis Pleiko, Kristina Põšnograjeva, Maarja Haugas, et al.
Pharmaceutics|December 28, 2021
PL1 Peptide Engages Acidic Surfaces on Tumor-Associated Fibronectin and Tenascin Isoforms to Trigger Cellular UptakePrakash Lingasamy, Kristina Põšnograjeva, Sergei Kopanchuk, et al.
Nanomaterials (Basel, Switzerland)|December 24, 2021
Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in EndometriosisLorena Simón-Gracia, Kristina Kiisholts, Vilma Petrikaitė, et al.
Scientific Reports|April 4, 2020
Tumor-penetrating peptide for systemic targeting of Tenascin-CPrakash Lingasamy, Allan Tobi, Kaarel Kurm, et al.
Drug Delivery and Translational Research|July 16, 2024
Protease-activated CendR peptides targeting tenascin-C: mitigating off-target tissue accumulationAllan Tobi, Maarja Haugas, Kristina Rabi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 13, 2017
Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticlesHedi Hunt, Lorena Simón-Gracia, Allan Tobi, et al.
Biomaterials|August 3, 2019
Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor deliveryPrakash Lingasamy, Allan Tobi, Maarja Haugas, et al.
Pageof 2